Click to Enlarge
Facebook
Twitter
The Financial Times’ main story focuses on a battle over the future of UK drug manufacturing giant GSK. US hedge fund Elliott Management, known for using its shareholdings to put pressure on companies’ management teams, has bought a multi-billion pound stake in GSK amid concerns by shareholders over the firm’s pipeline of future drugs and its R&D spending.

Financial Times Front Page 9th of December 2025

Paramount has made an all‑cash bid for Warner Bros Discovery, derailing Netflix’s agreed deal. Backed by investors linked to Jared Kushner and Gulf capital, the move forces WBD’s board to reassess options and could reshape studio alliances and streaming competition.

Read More »

Financial Times Front Page 8th of December 2025

The Fed is poised to cut rates, even as officials split over the outlook under Trump. Softer jobs data and slowing pay for low earners support easing, but critics warn it risks fuelling prices and frothy assets. The White House is ready to defend the decision.

Read More »

Financial Times Front Page 4th of December 2025

Bond investors cautioned the US Treasury that selecting Kevin Hassett to replace Powell as Fed chair could unsettle markets, citing worries over his perceived political ties and potential for sweeping rate cuts. Officials said the selection process continues, with alternatives under review.

Read More »